Abbott Laboratories

NYSE:ABT   4:00:00 PM EDT
98.46
+0.41 (+0.42%)
: $98.46 0.00 (0.00%)
Products

FDA Approves Labeling Update For Abbott's Heartmate 3 Heart Pump For Use In Pediatric Patients

Published: 12/17/2020 21:56 GMT
Abbott Laboratories (ABT) - FDA Approves Labeling Update for Abbott's Heartmate 3 Heart Pump for Use in Pediatric Patients.
Abbott Laboratories - Abbott's Heartmate 3™ Heart Pump Approved for Use for Pediatric Patients Battling Advanced Heart Failure.